NSE: COLPAL · 7 October 2026
- Colgate Palmolive Ltd. (COLPAL) shares declined 2.87% on Tuesday, closing at ₹1,757.40 after opening at ₹1,799.00 and touching an intraday low of ₹1,757.40.
- Colgate successfully executed a major oral health screening initiative, reaching 308,106 students across 547 CBSE-affiliated schools in Tamil Nadu and Puducherry within a 10-day sprint from August 17 to August 28, 2026. Serving as principal sponsor, the company collaborated with the Narcotics Control Bureau, CBSE, and the Indian Dental Association of Tamil Nadu, mobilizing 2,100 dentists and 29 regional dental colleges across 40 districts. This benchmark effort was officially recognized by the World Records Union under the company's long-term Bright Smiles, Bright Futures program and 2030 SMILE Strategy.
- Trading volume was 0.44 times the 20-day average daily volume.
Why is Colgate Palmolive share price falling on 7 October 2026?
Colgate Palmolive Ltd. (COLPAL) shares declined 2.87% on Tuesday, closing at ₹1,757.40 after opening at ₹1,799.00 and touching an intraday low of ₹1,757.40.
The broader market also faced downward pressure during the session, with the Nifty benchmark declining 0.76%. COLPAL's move underperformed the broader market, extending its recent 20-day return to -2.37% following prior short-term gains of 1.94% and 4.29% over the preceding two sessions.
While the company recently announced a record-setting oral health screening initiative reaching over 300,000 students in Tamil Nadu and Puducherry within a 10-day period ending August 28, 2026, alongside executive management changes announced in late September, no specific catalyst was officially reported to explain today's price action. The decline appears technical and aligns with profit-taking following recent short-term gains rather than any new operational trigger.
1.80 lakh shares traded by 7 October 2026 · 03:10 PM IST. This compares with a 20-day average daily volume of 4.06 lakh shares (0.44 times). The five-day average daily volume was 2.84 lakh shares. Separately, the NSE report for 6 October 2026 showed 3.79 lakh shares delivered, representing 67.90% of that day’s traded volume. The same report recorded 18,438 trades.
With no same-day corporate announcement or fundamental trigger reported, today's 2.87% decline appears driven by profit-taking following consecutive short-term gains of 1.94% and 4.29% over the prior two sessions amid subdued cash-market volume.
Latest Company Developments
Colgate successfully executed a major oral health screening initiative, reaching 308,106 students across 547 CBSE-affiliated schools in Tamil Nadu and Puducherry within a 10-day sprint from August 17 to August 28, 2026. Serving as principal sponsor, the company collaborated with the Narcotics Control Bureau, CBSE, and the Indian Dental Association of Tamil Nadu, mobilizing 2,100 dentists and 29 regional dental colleges across 40 districts. This benchmark effort was officially recognized by the World Records Union under the company's long-term Bright Smiles, Bright Futures program and 2030 SMILE Strategy.
Demonstrates the company's large-scale operational execution in public health outreach and strengthens its brand equity across foundational consumer segments.
The company's Board of Directors noted the resignation of Mr. Priyan Pillay as Executive Vice President – Legal, effective October 23, 2026, as he relocates back to his home country. In succession, the board approved the appointment of Mr. Abhijit Yadav, currently serving as Legal Director, to the role of Executive Vice President – Legal, effective October 24, 2026. Mr. Yadav has been with the company since 2019 and brings nearly two decades of legal experience across the FMCG and pharma sectors.
Ensures leadership continuity in legal and regulatory compliance governance through an internal promotion following a planned departure.
Appointment of Abhijit Yadav as Executive Vice-President – Legal of the company effective. October 24, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 7.23% on 30 June 2026. This compares with 7.45% on 31 March 2026, a change of -0.22 percentage points.
The filing reported 33 MF/UTI holders.
What to Watch Next
- Execution progress of the 2030 SMILE Strategy and community health outreach programs
- Transition of senior management roles, including the incoming legal leadership effective in late October
- Volume participation and delivery percentage trends relative to the 20-day average volume
- Sectoral performance of the Nifty FMCG benchmark
Other Dated Coverage
- Why COLPAL Shares Rose 2.31% Today: Price Action & Context | 5 October 2026 — 5 October 2026
- Why COLPAL Shares Fell 2.01% Today Near 52-Week Lows | 1 October 2026 — 1 October 2026
- Why Colgate Palmolive Shares Fell 1.22% Today to 52-Week Lows | 30 September 2026 — 30 September 2026
More Colgate Palmolive news and dated analysis →
Frequently Asked Questions
What is the latest Colgate Palmolive company news?
Colgate successfully executed a major oral health screening initiative, reaching 308,106 students across 547 CBSE-affiliated schools in Tamil Nadu and Puducherry within a 10-day sprint from August 17 to August 28, 2026. Serving as principal sponsor, the company collaborated with the Narcotics Control Bureau, CBSE, and the Indian Dental Association of Tamil Nadu, mobilizing 2,100 dentists and 29 regional dental colleges across 40 districts. This benchmark effort was officially recognized by the World Records Union under the company's long-term Bright Smiles, Bright Futures program and 2030 SMILE Strategy.
How strong was Colgate Palmolive’s trading volume?
1.80 lakh shares traded, 0.44 times the 20-day average daily volume. The price and volume data are dated 7 October 2026 · 03:10 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.